pirtobrutinib,rituximab,venetoclax
eli lilly,roche,abbvie
['bruin', 'cll', 'bruin cll-322']
in this new video, jennifer woyach, md, of speaks about the bruin cll-322 study, which is enrolling patients with previously treated cll/sll. dr. woyach presented information about the study's design and enrollment process at #asco23. : 
Translating Hematologic Oncology Discoveries into Practice.